Providence St. Joseph Health

Providence St. Joseph Health Digital Commons
Articles, Abstracts, and Reports
12-1-2017

NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling
modulates normoxic HIF-1α
HIF-1 and p27
Smitha Antony
Guojian Jiang
Yongzhong Wu
Jennifer L Meitzler
Hala R Makhlouf

See next page for additional authors

Follow this and additional works at: https://digitalcommons.psjhealth.org/publications
Part of the Oncology Commons

Recommended Citation
Antony, Smitha; Jiang, Guojian; Wu, Yongzhong; Meitzler, Jennifer L; Makhlouf, Hala R; Haines, Diana C;
Butcher, Donna; Hoon, Dave S B; Ji, Jiuping; Zhang, Yiping; Juhasz, Agnes; Lu, Jiamo; Liu, Han; Dahan, Iris;
Konate, Mariam; Roy, Krishnendu K; and Doroshow, James H, "NADPH oxidase 5 (NOX5)-induced reactive
oxygen signaling modulates normoxic HIF-1α and p27" (2017). Articles, Abstracts, and Reports. 2314.
https://digitalcommons.psjhealth.org/publications/2314

This Article is brought to you for free and open access by Providence St. Joseph Health Digital Commons. It has
been accepted for inclusion in Articles, Abstracts, and Reports by an authorized administrator of Providence St.
Joseph Health Digital Commons. For more information, please contact digitalcommons@providence.org.

Authors
Smitha Antony, Guojian Jiang, Yongzhong Wu, Jennifer L Meitzler, Hala R Makhlouf, Diana C Haines,
Donna Butcher, Dave S B Hoon, Jiuping Ji, Yiping Zhang, Agnes Juhasz, Jiamo Lu, Han Liu, Iris Dahan,
Mariam Konate, Krishnendu K Roy, and James H Doroshow

This article is available at Providence St. Joseph Health Digital Commons: https://digitalcommons.psjhealth.org/
publications/2314

Received: 27 March 2017

|

Revised: 19 July 2017

|

Accepted: 28 July 2017

DOI: 10.1002/mc.22708

RESEARCH ARTICLE

NADPH oxidase 5 (NOX5)—induced reactive oxygen signaling
modulates normoxic HIF-1α and p27Kip1 expression in
malignant melanoma and other human tumors
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NADPH oxidase 5 (NOX5) generated reactive oxygen species (ROS) have been
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implicated in signaling cascades that regulate cancer cell proliferation. To evaluate and
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validate NOX5 expression in human tumors, we screened a broad range of tissue
microarrays (TMAs), and report substantial overexpression of NOX5 in malignant
melanoma and cancers of the prostate, breast, and ovary. In human UACC-257
melanoma cells that possesses high levels of functional endogenous NOX5, overexpression of NOX5 resulted in enhanced cell growth, increased numbers of BrdU
positive cells, and increased γ-H2AX levels. Additionally, NOX5-overexpressing (stable
and inducible) UACC-257 cells demonstrated increased normoxic HIF-1α expression
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and decreased p27Kip1 expression. Similarly, increased normoxic HIF-1α expression and
decreased p27Kip1 expression were observed in stable NOX5-overexpressing clones of
KARPAS 299 human lymphoma cells and in the human prostate cancer cell line, PC-3.
Conversely, knockdown of endogenous NOX5 in UACC-257 cells resulted in decreased
cell growth, decreased HIF-1α expression, and increased p27Kip1 expression. Likewise,
in an additional human melanoma cell line, WM852, and in PC-3 cells, transient
knockdown of endogenous NOX5 resulted in increased p27Kip1 and decreased HIF-1α
expression. Knockdown of endogenous NOX5 in UACC-257 cells resulted in decreased
Akt and GSK3β phosphorylation, signaling pathways known to modulate p27Kip1 levels.
In summary, our findings suggest that NOX5 expression in human UACC-257 melanoma

Abbreviations: 7 AAD, 7-aminoactinomycin D; Akt, protein kinase B; ALK, anaplastic lymphoma kinase; AMPK, 5′ adenosine monophosphate-activated protein kinase; BAPTA-AM, 1,2-Bis(2aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl ester); BrdU, 5-bromo-2′-deoxyuridine; Ca2+, calcium ions; CDK, cyclin-dependent kinases; DCF, 2′,7′-dichlorofluorescein; DPI, diphenyleneiodonium; DTT, dithiothreitol; DNase, deoxyribonuclease; DUOX, dual oxidase; FAD, flavin adenine dinucleotide; Fe2+, ferrous ion; FOXO, forkhead box protein O;
G418, geneticin; GSK3, glycogen synthase kinase 3; H2-DCFDA, 2′,7′-dichlorodihydrofluorescein diacetate; H2O2, hydrogen peroxide; H2AX, histone H2AX; HA-tag, hemagglutinin tag; HIF1α, hypoxia-inducible factor 1-alpha; HRP, horseradish peroxidase; KRPG, krebs-ringer phosphate glucose buffer; MAPK, mitogen activated protein kinase; NAC, N-Acetyl-L-Cysteine;
NADP+, nicotinamide adenine dinucleotide phosphate oxidized; NADPH, nicotinamide adenine dinucleotide phosphate reduced; NOX, NADPH oxidase; p27Kip1, cyclin-dependent kinase
inhibitor 1B; PBS, phosphate-buffered saline; PEG, polyethylene glycol; PIM, proto-oncogene serine/threonine-protein kinase; PMA, phorbol-12-myristate-13-acetate; RT-PCR, reverse
transcription—polymerase chain reaction; ROS, reactive oxygen species; SDS, sodium dodecyl sulfate; SOD, superoxide dismutase; sh, short hairpin; siRNA, small interfering RNA; TBST, trisbuffered saline with 0.1% Tween 20; TMA, tissue microarray.
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cells could contribute to cell proliferation due, in part, to the generation of high local
concentrations of extracellular ROS that modulate multiple pathways that regulate HIF1α and networks that signal through Akt/GSK3β/p27Kip1.
KEYWORDS

Akt/GSK3 signaling, cell growth, DNA damage, NADPH oxidase, reactive oxygen species
(ROS), tumor microarray (TMA)

1 | INTRODUCTION

with a frequency of intermediate to strong expression in 57-70% of
several human tumors, including prostate cancer and melanoma.22

A growing body of evidence supports a dual role for reactive oxygen

Detection of elevated expression levels of NOX5 in a variety of human

species (ROS) as signaling molecules.1–3 Controlled ROS production

malignancies led us to further explore the functional significance of

regulates normal cellular physiological functions4; but in excess, ROS are

NOX5 in the context of tumorigenesis.

1,5,6

In this study, we performed a more detailed evaluation of NOX5

Much recent research has focused on how low levels of intracellular ROS

expression across several tumor microarrays to assess the frequency of

(10-100 nM) regulate tumor growth by facilitating mutagenesis, tumor

NOX5 expression in a larger sample of human malignancies. Here, we

initiation, and tumor promotion.6,7 Members of the NAPDH oxidase

validate our initial findings and report substantial overexpression of

(NOX) family play a major role in generating ROS in a broad range of cell

NOX5, compared to histologically normal tissues, in several human

types.1,8–10 This 7-membered family is comprised of NOXes 1-5 and

cancers including those of prostate and breast and in malignant melanoma.

DUOX 1 and 2 proteins that function to generate ROS by oxidizing

We also report NOX5 expression across a panel of human melanoma cell

NADPH to NADP+.11–13 The vital roles that NOX-mediated ROS play in

lines, with the UACC-257 line having the highest endogenous expression.

host defense, metabolism, and the control of vascular tone are well

Functional NOX5-derived ROS production in UACC-257 cells regulates

documented.14–16 More recently, several studies have reported upregu-

normoxic HIF-1α and p27Kip1 expression. Additionally, NOX5 over-

lated RNA and protein expression levels of the NOX family of proteins in

expression modulates γH2AX levels and the growth of the UACC-257

human tumors, as well as a link between expression levels and cancer cell

melanoma line. These results were confirmed in additional human tumor

detrimental to the cell resulting in cell differentiation and/or cell death.

6,9,10,17,18

proliferation.

NOX1 expression has been linked to colon cancer;

cell models that possess functional NOX5 activity.

a role for NOX1 in the etiology of gastric and prostate cancers has also
been suggested.9,17,19,20 Increased NOX4 expression has been found
predominantly in tumors of the brain, ovary, and kidney, as well as in
melanoma.9,17,21 NOX5 has been measured primarily in the context of
prostate, breast, and esophageal cancer22–25; and DUOX1 and DUOX2
have been found in thyroid, lung, and pancreatic cancers.9,17,26

2 | MATERIALS AND METHO DS
2.1 | Reagents and antibodies
Anti-β-Actin antibody (#A3853), N-Acetyl-L-Cysteine (NAC; #A7250),

Of the tumor-associated NOXes reported thus far, the role of

Doxycycline hydrochloride (#D3447), Ampicillin sodium salt (#A0166),

NADPH oxidase 5 (NOX5) is the least well understood; largely, this is

Diphenyleneiodonium chloride (DPI; #D-2926), Catalase (#C1345), PEG-

because of a paucity of animal-based studies due to the lack of NOX5

Catalase (#C4963), and PEG-SOD (#S9549) were purchased from Sigma-

expression in rodents.27–29 Structurally like the other NOXes, NOX5 is

Aldrich (St. Louis, MO); Geneticin G418 (#G5005) was from Teknova

anchored to the plasma membrane through its six transmembrane

(Hollister, CA); Ionomycin (#407952), Phorbol-12-myristate-13-acetate

helices that can bind two heme cofactors and allow for NADPH

(PMA; #524400), and BAPTA-AM (#196419) were from EMD Chemicals

oxidation through a C-terminal FAD/NADPH binding domain.17,30–35

(Billerica, MA); Akt (#4691), p-Akt (Ser473) (#4058), GSK3β (#9315), p-

However, although regulated by calcium, NOX5 has no known

GSK3β (Ser9) (#9336), Lamin A/C (#2032), SKP2 (#4313) antibodies were

interaction partner essential for its activity.

29,35,36

Several studies

from Cell Signaling Technology (Danvers; MA); HIF-1α (#610959) and

;

p27Kip1 (#610241) antibodies were from BD Biosciences (San Jose, CA);

yet, limited evidence exists detailing the signaling role of NOX5 in

p27Kip1 phospho (pT157) (#T3757) and p27Kip1 phospho (pS10)

tumor biology. Such studies include, but are not limited to, explorations

(#ab62364) antibodies were purchased from Abcam (Cambridge, MA);

of the role of NOX5 in hairy cell leukemia,38 ALK-positive anaplastic

and Anti-HA antibody (#11867423001) was purchased from Roche-

report correlations between NOX5 expression and tumorigenesis

39

22,24,40

23,37

and esophageal ade-

Applied Science (Indianapolis, IN). Restriction enzymes BamH1

nocarcinoma.25,41,42 Recently, our laboratory reported the characteri-

(#R0136S), BglII (#R0144S), ECORV (#R0195S) and T4 DNA ligase

zation of NOX5 expression in human tumors and tumor cell lines using

(#M0202S) were purchased from New England Biolabs (Ipswich, MA).

a new NOX5 monoclonal antibody.22 Preliminary human tumor

Opti-MEM® reduced serum medium (#11058-021), MAX Efficiency®

microarray (TMA) analysis revealed high levels of NOX5 expression,

DH5α™ competent Cells (#18258012), Puromycin dihydrochloride

large-cell lymphoma,

prostate cancer,
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(#A1113803), 2′,7′-Dichlorodihydrofluorescin diacetate (H2-DCFDA,

inducible expression system, the Tet-On 3G inducible expression

#D399) were obtained from Thermo Fisher Scientific (Rockford, IL). LB

system (#631167, Clontech) that contains the regulator plasmid

plates containing ampicillin (#BPL-2200) were purchased from KD

pEF1α-Tet3G and the response plasmid pTRE3G was used. To clone

Medical (Columbia, MD). Human anti-NOX5 antibody was previously

NOX5β into the pTRE3G vector, the pcDNA3-NOX5β plasmid was

developed by Creative Biolabs (Port Jefferson Station, NY) and

digested with BamH1 and ECORV, and the pTRE3G vector was

characterized by our laboratory. NOX5β (accession number AF325189)

digested with BglII and ECORV. Subsequent to purification of the

subcloned into a modified pcDNA3 containing an N-terminal HA epitope

fragments and ligation using T4 ligase and transformation in DH5α

was a kind gift from Dr. David J. R. Fulton (Medical College of Georgia).

competent cells, ampicillin-resistant single bacterial colonies were
isolated and the plasmid DNA was isolated (QIAprep® spin miniprep
kit, #27104, Qiagen, Germantown, MD). Purified plasmid DNA was

2.2 | Cell culture and transfection

confirmed by restriction enzyme digestion and sequencing as the

The human melanoma cell lines LOX IMVI, M14, MALME-3M,

pTRE3G-NOX5β expression plasmid.

SK-MEL-2, SK-MEL-5, SK-MEL-28, UACC-62, and UACC-257 were

To generate UACC-257 cells that express inducible NOX5,

obtained from the Developmental Therapeutics Program, Division of

parental UACC-257 cells were transfected with the pEF1α-Tet3G

Cancer Treatment and Diagnosis of the National Cancer Institute,

vector and clones that were resistant to G418 and constitutively

Frederick,

medium

express the Tet-On 3G transactivator were selected. Positive clones

(SH30255.01; HyClone) supplemented with 10% FBS (#100-106;

were next transfected with the pTRE3G-NOX5β expression vector

Gemini Bio Products). The melanoma cell lines Lu1205 (#1205 Lu-

along with a linear selection marker (Purr). After a second round of

01-0001), WM115 (#WM115-01-0001), WM852 (#WM852-01-

selection, double-stable clones (G418 and puromycin resistant) that

0001), and WM1158 (#WM1158-01-0001) were obtained from

express high levels of NOX5 in response to doxycycline were

Rockland Immunochemicals Inc., and maintained in 2% melanoma

established.

MD

and

were

cultured

in

RPMI-1640

media (4:1 mixture of MCDB153 and L15, supplemented with 2 mM

For gene silencing experiments, log-phase cells (UACC-257, PC-3,

Ca2+, 2% FBS, and 5 μg/mL insulin). The melanoma cell lines

WM852) were trypsinized and transfected with 5 nM of either control

SK-MEL-3 (#HTB-69), G-361 (#CRL-1424), and HT-144 (#HTB-63)

or three different NOX5 Stealth Select RNAi's (Stealth Select RNAi™

were obtained from ATCC and maintained in McCoy's 5a Medium

siRNA #HSS128401, #HSS128402, #HSS128403, Invitrogen) using the

Modified (#30-2007, ATCC) with 15% FBS for SK-MEL-3 and G-361

Lipofectamine™ RNAiMAX transfection reagent (#13778-075, Invitro-

cells and 10% FBS for HT-144 cells. A375 (#CRL-1619), A2058

gen). After 72 h of transfection, silencing efficiency was analyzed by

(#CRL-11147), SH-4 (# CRL-7724), and Hs895-T (#CRL-7637)

measuring NOX5 at the RNA level by TaqMan real-time PCR and/or

melanoma cell lines from ATCC were maintained in Dulbecco's

protein level by immunoblotting. Stealth scrambled siRNA transfections

Modified Eagle's Medium (#30-2002, ATCC) with 10% FBS. Hs895-

(Stealth RNAi Negative Control Duplexes #12935-100, Invitrogen)

Sk (#CRL-7636) cell line from ATCC was maintained in Dulbecco's

were used as controls. Effect of transient NOX5 knockdown on the

modified Eagle's medium (4 mM L-glutamine adjusted to contain

growth of WM852 cells was evaluated 6 days after log-phase cells were

1.5 g/L sodium bicarbonate, 4.5 g/L glucose) containing 10% FBS.

trypsinized and transfected with 5 nM of either scrambled control siRNA

RPMI-7951 (#HTB-66) and SK-MEL-24 (#HTB-71) melanoma cell

or two different NOX5 Stealth Select RNAi's (Stealth Select RNAi™

lines from ATCC were maintained in Eagle's Minimum Essential

siRNA #HSS128401 and #HSS128402, Invitrogen) using the Lipofect-

Medium (#30-2003, ATCC) containing 10% and 15% FBS, respec-

amine™ RNAiMAX transfection reagent (#13778-075, Invitrogen). To

tively. PC-3 human prostate cancer cells (#CRL-1435) were obtained

evaluate the effect of HIF-1α, UACC-257 cells that stably overexpress

from ATCC and maintained in F-12 K medium (#30-2004, ATCC)

NOX5 (Clone 3) and WM852 cells were transiently transfected with

supplemented with 10% FBS. Human KARPAS 299 lymphoma cell

either control scrambled siRNA (Stealth RNAi Negative Control

line (#06072604) was obtained from Sigma and cultured in RPMI-

Duplexes #12935-100, Invitrogen) or with two different HIF-1α

1640 medium supplemented with 2 mM glutamine and 10% FBS. All

Silencer® Select RNAi's (#s6539 and #s6541, Invitrogen) using the

cell lines were maintained at 37°C in 5% CO2 and 95% air and

Lipofectamine™ RNAiMAX transfection reagent (#13778-075, Invitro-

humidified atmosphere. The identity of the cell lines was confirmed

gen) and evaluated 6 days after transfection.

by the Genetic Resources Core Facility of Johns Hopkins University
(Baltimore, MD).

To generate UACC-257 cells that are stably knocked down for
NOX5 expression, three different NOX5shRNA plasmids that target

Transfection was carried out using Lipofectamine® 2000

different sequences on NOX5, and the control shRNA plasmid, were

(#11668019, Invitrogen/Thermo Fisher Scientific) according to the

purchased from Qiagen (#336313, KH17569N). Parental UACC-257

manufacturer's protocol. To generate cells that stably overexpress

cells were transfected with the four plasmids individually and selected

NOX5 (UACC-257, PC-3 and KARPAS 299), cells were transfected

with G418 at a concentration of 700 μg/ml. G418-resistant clones

with a pcDNA3-NOX5β plasmid (kind gift from Dr. Fulton) or empty

were screened and examined for NOX5 expression at both the mRNA

vector using Lipofectamine® 2000. Resistant clones were selected

and protein levels; validated vector shRNA clones and NOX5shRNA

with 700 µg/mL of G418, and then single clones were selected and

clones derived from three different NOX5shRNA plasmids were

maintained under G418 selection. For generating the NOX5-

maintained under G418 selection.
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5′-TGCATAACAAGTTTTGGCAAGA-3′ and antisense 5′-ATCCCATCTGTTTGACTGAGGT-3′ (product size: 76 bp); NOX5, sense

Unstained slides from formalin-fixed, paraffin-embedded tissue microarray (TMA) blocks were purchased from US Biomax. These included:
Colon disease tissue arrays #BC05002 and # CO809a; Breast invasive
ductal carcinoma tissue array #BC08118; Breast cancer tissue array
#BR1505b; Lung cancer tissue array #LC2085b; Mid-advanced stage
ovary cancer tissue array #OV8010; Prostate cancer tissue array
#PR2085b; and Tissue array of gastritis with intestinal metaplasia and
gastric carcinoma #IC00011. Melanoma stage III YTMA-144-4 array and
Melanoma stage IV YTMA-205-2 array were a kind gift of Dr. Dave S.
Hoon (John Wayne Cancer Institute, CA). NOX5 immunohistochemical
(IHC) positive/negative control slides were prepared from a formalinfixed, paraffin embedded cell pellet control block. Immunohistochemical
staining was performed with a Leica Biosystems’ Bond-Max autostainer,
beginning with heat-induced epitope retrieval in citrate buffer. The
Intense R Detection Kit (#DS9263, Leica Biosystems) was used in
addition to a normal horse serum block (Vector Labs) and biotinylated
horse anti-mouse IgG (Vector Labs). NOX5 was used at 1:1000 for
30 min. Negative control slides were exposed to a normal mouse IgG2a
isotype reagent (#550339, BD Bioscience) in place of primary antibody.
NOX5 expression was assessed in a comprehensive library of
formalin-fixed, paraffin-embedded tissue samples (TMAs) of 2091
cases (that were found to be adequate for scoring) out of a total of
2414 tumors of various epithelial origins (colon, prostate, breast, small
intestine, stomach, ovary), melanomas, as well as various inflammatory
diseases and normal control tissues. Staining intensities were assessed
by two pathologists as, 0 = negative/no or blush staining, 1+ = weak, 2
+ = moderate, and 3+ = strong. The percentage of stained tumor/lesion
cells was estimated for each case where, 0 = 0% to < 10% were
considered negative, 1 = 10-24%, 2 = 25-49%, 3 = ≥50% of positive
cells. Cases with moderate to strong cytoplasmic reactivity of the
antibody on ≥10% of cells were considered high expressors.

5′-AAGACTCCATCACGGGGCTGCA-3′ and antisense 5′-CCCTTC
AGCACCTTGGCCAGA-3′ (product size: 144 bp); DUOX1 and 2,
sense

5′-CAGTTTGAGTGGCTGGCTGACA-3′

5′-GAGGTCGAACTTCTCAGCCAGC-3′

and

(product

size:

antisense
108 bp).

NOX5 may exist either as the long NOX5-L or short NOX5-S
isoform. The sequence of NOX5-S is the same as the sequence at
the

3′

end

of

NOX5-L.

The

primers

(5′-GGAGGATGC-

CAGGTGGCTCCGGT-3′ and antisense 5′-AGCCCCACTACCACGTAGCCC-3′) covering a region of NOX5-L, but not NOX5-S, were
used to determine which NOX5 isoform was present in UACC-257
and SK-MEL-5 melanoma cell lines.42 The primers are also common
to NOX5 isoforms α, β, γ, and δ. To further identify the long form
variant of NOX5 present, primers designed for α and γ variants,
sense

5′-GGCCCTGAAGGCTGTAGAGGCA-3′

5′-GCGCAGCTCATCCGGGTCAATG-3′

and

(product

size:

antisense
326

and

451 bp, respectively); and for β and δ variants, sense 5′- CAGGACGGTACTCCGCTGACACCTT-3′

and

antisense

5′-GCGCAGCT-

CATCCGGGTCAATG-3′ (product size: 577 and 661 bp, respectively)
were generated.43 All PCR products were electrophoresed on 2%
agarose gels.
For quantitative real-time PCR, total RNA was extracted from cells
using the RNeasy Mini Kit (#74104, Qiagen) following the manufacturer's instructions. Two microgram of total RNA was used for cDNA
synthesis using SuperScript II reverse transcriptase (#100004925,
Invitrogen) and random primers (#48190-011, Invitrogen) in a 20 µL
reaction system. The cycling conditions were as follows: 25°C for
5 min, 42°C for 50 min, 75°C for 5 min. After reaction, the products
were diluted with diethyl pyrocarbonate/H2O to 100 µL for the realtime PCR. Real-time PCR was performed on 384-well plates in a 20-µL
reaction system containing 2 µL of diluted cDNA, 1 µL of appropriate
primer (Applied Biosystems TaqMan gene expression assay primers
from Thermo Fisher Scientific; Human β-Actin assay primer
Hs99999903_m1; NOX5 assay primer Hs00225846_m1; Human
HIF-1α

2.4 | RNA analysis: extraction, cDNA synthesis,
and quantitative real-time PCR assay

assay

primer

Hs00153153_m1;

Human

CDKN1B

[p27Kip1] assay primer Hs00153277_m1; and Human SKP2 assay
primer Hs01021864_m1), 7 µL of H2O, and 10 µL of TaqMan 2 × gene

Total RNA was isolated from cells with the RNeasy Mini Kit (#74104,

expression master mix reagent (#4304437). The PCR was carried out

Qiagen) according to the manufacturer's protocol. RNA was treated

using the default cycling conditions, and fluorescence was detected

with DNase (#79254, Qiagen) according to the manufacturer's

with the ABI 7900HT sequence detection system (Applied Biosystems,

specifications (Applied Biosystems, Austin, TX). RNA concentrations

Foster City, CA). Triplicate determinations were performed for each

and purity were measured on the NanoDrop ND-1000 apparatus

sample that was used for the real-time PCR; the mean value was

(Thermo Fisher Scientific). First-strand cDNA was synthesized with a

calculated, and the data in the final figures represents three

high-capacity RNA-to-cDNA™ kit (#4387406, Applied Biosystems)

independent experiments. Relative gene expression was calculated

according to the manufacturer's guidelines. Primers were generated

as the ratio of the target gene to the internal reference gene (β-Actin)

that were specific to each transcript,42 for NOX1, sense 5′-

multiplied by 106 based on the Ct values.

TGGTCATGCAGCATTAAACTTT-3′

and

antisense

5′-AAAACT-

CATTGTCCCACATTGG-3′ (product size: 98 bp); NOX2, sense 5′GAGTCTCAGGCCAATCACTTTG-3′

and

antisense

5′-

AGTTGGGCCGTCCATACAAAGT-3′ (product size: 94 bp); NOX3,

2.5 | Intracellular ROS detection by confocal
microscopy

sense 5′-TTCTTCTGTGGACCTAAAGCTC-3′ and antisense 5′-AA-

For detection of intracellular ROS by confocal microscopy, cells were

TAGAAATGAACACCTCTGGG-3′ (product size: 91 bp); NOX4, sense

seeded in 6-well plates at a density of 1 × 106 cells per well in growth
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medium overnight. The next day the cells were washed twice with

were added to the samples in a final volume of 200 μL. The samples were

phosphate-buffered saline (PBS, pH 7.4), and 10 µmol/L H2-DCFDA in

mixed and placed immediately into a luminometer, and the chemilumi-

PBS was applied to live cells for 15 min at 37°C in the dark on the stage

nescence was measured every 30 s for 20 min. Assays were performed in

of a confocal microscope. H2-DCFDA-loaded cells were rinsed twice in

triplicate. For treatment with DPI (200 nmol/L), cells were pretreated for

PBS, and then either stimulated with 1 µmol/L ionomycin or exposed

2 h in culture medium prior to the assay. To evaluate the effect of PMA

to medium for 5 min at 37°C in the dark. Confocal microscopy was

and BAPTA on NOX5-mediated ROS production, 100 μL assay buffer

performed using an Olympus Fluoview scanning unit equipped with an

containing the reagents for luminol oxidation and the enhancer was

argon-krypton laser at 488 nm mounted on an Olympus reflected

prepared to contain either PMA (1 μL of a 40 μmol/L PMA stock solution)

fluorescence microscope (Olympus, Nagano, Japan). During scanning

or BAPTA (1 μL of a 2 mmol/L BAPTA stock solution) or DMSO control

of H2-DCFDA-loaded cells, we observed that prolonged (more than

(1 μL). This was then added to 100 μL of assay medium containing cells to

5 s) irradiation with the xenon lamp or slow scanning with the 488-nm

yield a final concentration of 200 nmol/L PMA and 10 μmol/L of BAPTA in

laser line caused probe oxidation and an artifactual increase in

a total volume of 200 μL in 96-well plates. The samples were mixed and

fluorescence. To avoid this artifact, the cells were initially brought into

placed immediately into a luminometer, and the chemiluminescence was

focus using standard epifluorescence (xenon lamp excitation). Then,

measured every 30 s for 20 min at 37°C. The specificity of the superoxide

the epifluorescence was switched off and the specimen was moved

assay was assessed by treatment with superoxide dismutase (SOD)

beyond the previously illuminated area. A single scan at one focal plane

provided in the kit. Under similar assay conditions, cells that stably

using minimum laser intensity (10%) was obtained, and the image was

overexpress NOX5 generated superoxide as measured by luminescence

saved for subsequent measurement of fluorescence intensity with the

intensities in the range of >107 arbitrary units (see Supplementary

Olympus proprietary Fluoview software.

Figure S2). To maintain luminescence intensities within comparable values
to the UACC-257 parental cells, vector, and NOX5 stable knockdown

2.6 | Extracellular H2O2 measurement using Amplex
Red®

cells, only 100 000 cells/sample of UACC-257-NOX5 stably overexpressing cells were used (for Figure 3C, lower panel), and the assay
was carried out in the absence of an enhancer.

The Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit (#A22188,
Invitrogen) was used to detect the extracellular H2O2 released by live
cells. Briefly, log-phase UACC-257 cells stably overexpressing NOX5
(Clone 3) were either not treated or treated with 200 nmol/L of

2.8 | Preparation of nuclear extracts and whole cell
lysates

diphenyleneiodonium (DPI) for 2 h. The cells were then washed twice

Nuclear extracts were prepared according to the instructions of the nuclear

with 1 × PBS, trypsinized, and dispersed thoroughly to produce a

and cytoplasmic extraction kit (# 78833, Thermo Fisher Scientific). Briefly,

4

20-µL cell suspension containing 2 × 10 cells in 1 × KRPG (Krebs-

cells were re-suspended in 10 vol of CER I solution containing protease

Ringer phosphate glucose) buffer. The cells were mixed with 100 µL of

inhibitors, after which they were incubated in CER II solution on ice for 1 min

Amplex Red® reagent containing 50 µmol/L Amplex Red and 0.1

and homogenized. Nuclei were recovered by centrifugation at 14 000 rpm

units/mL of horseradish peroxidase (HRP) in KRPG buffer with or

for 5 min, and the supernatant was kept as the cytoplasmic extract. The

without 1 µmol/L ionomycin or 500 nmol/L phorbol-12-myristate-13-

nuclear pellet was suspended in NER solution containing protease inhibitors

acetate (PMA), and incubated at 37°C for 30 min. The fluorescence of

and kept on ice for 40 min. The insoluble pellet was removed by

the oxidized 10-acetyl-3,7-dihydroxyphenoxazine was measured at an

centrifugation at 14 000 rpm for 10 min. The supernatant was used as

excitation wavelength of 530 nm and an emission wavelength of

the nuclear extract. For whole cell lysates, cells were washed with PBS,

590 nm using a SpectraMax Multiplate reader (Molecular Devices,

harvested and lysed with 1 × RIPA lysis buffer (#20-188, Millipore,

Sunnyvale, CA). H2O2 was quantified using an H2O2 standard curve

Temecula, CA) with the addition of a phosphatase inhibitor tablet (#04-

over a 0-2 μmol/L concentration range. Each value in the figures

906-837001, Roche Applied Science, Indianapolis, IN) and a protease

represents a mean of triplicate samples.

inhibitor tablet (Roche, #11-836-153001). Protein concentration was
estimated using the Pierce™ BCA Protein Assay Kit (#23227, Thermo Fisher

2.7 | Determination of superoxide generation using a
chemiluminescence assay
Superoxide production was assessed with a commercially available

Scientific), and bovine serum albumin (BSA) was used as the standard.

2.9 | Western analysis

superoxide anion assay kit (# CS1000-1KT, Sigma-Aldrich) utilizing the

The nuclear extracts and whole cell lysates were mixed with an equal

manufacturer's instructions. The kit is based on the oxidation of luminol by

volume of 2 × SDS protein gel loading buffer (#351-082-661, Quality

superoxide anion resulting in the formation of chemiluminescent light. A

Biological), and 40 µg of each was loaded onto a 4-20% Tris glycine gel

specific, non-toxic enhancer amplifies the chemiluminescent signal.

(# EC6028, Invitrogen). For detection of NOX5 expression, the

Briefly, 1 × 106 cells cultured in growth medium were washed and

extracts and lysates that were mixed with an equal volume of 2 × SDS

resuspended in 100 μL of assay medium in 96-well plates. To this, assay

loading buffer were not heated prior to loading onto gels. Subsequent

buffer containing the reagents for luminol oxidation and the enhancer

to gel separation, the proteins were electrophoretically transferred
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onto nitrocellulose membranes using I Blot gel transfer stacks (#IB

collected by trypsinization, centrifuged, and fixed in BD Cytofix/

3010-01, Invitrogen). The membranes were blocked in 1 × TBST buffer

Cytoperm Buffer. Cells were then permeabilized with BD Cytoperm

with 5% nonfat milk for 1 h at room temperature followed by

Permeabilization Buffer Plus, and fixed again with BD Cytofix/

incubation with the primary antibody overnight in TBST buffer.

Cytoperm Buffer. BrdU epitopes were exposed by re-suspending

Membranes were washed three times in 1 × TBST buffer and

the tumor cells in DNase (30 μg DNase/106 cells) at 37°C for 1 h. BrdU

incubated with horseradish peroxidase-conjugated secondary anti-

was stained with a fluorochrome-conjugated anti-BrdU antibody (1:50

body for 1 h at room temperature with shaking. Subsequent to washes

dilution, room temperature for 20 min). Total DNA was stained with

with TBST buffer, the antigen-antibody complex was visualized using

20 μL of a 7-aminoactinomycin D (7-AAD) solution (provided with the

the SuperSignal West Pico Luminol/Enhancer Solution (#1856136,

Kit) using a 5 min incubation. Tumor cells were then resuspended in

Thermo Fisher Scientific).

1 mL PBS. Stained cells were subsequently analyzed using a FACS

Densitometric analyses of every Western analysis in the manuscript
was performed using the Image Studio™ Software (LI-COR). For whole

Calibur Flow Cytometer (Becton Dickinson, San Jose, CA) equipped
with a 488-nm laser capable of detecting both 7-AAD and FITC.

cell lysates, protein expression densitometric analysis of each sample
was normalized to that of β-Actin. For samples involving nuclear and
cytoplasmic preparations, densitometric analysis was normalized to that
of β-Actin for cytoplasmic proteins and to that of Lamin A/C for nuclear
473

proteins respectively. For p-Akt (Ser

9

) and p-GSK3β (Ser ), normal-

izations were done to their respective total Akt and GSK3β proteins.

2.12 | H2AX ELISA assay
For the γ-H2AX immunoassay,44 96-well Pierce white opaque plates
were coated with anti-phospho-Histone H2AX (S139) mouse monoclonal antibody (Millipore, # 05-636) diluted to a concentration at
4 μg/mL in 0.1 M pH 9.6 carbonate buffer (Sigma Aldrich), 100 μL/well,

2.10 | Cell growth assay

for 2 h at 37°C. Plates were then blocked with 250 μL/well of
Superblock (Pierce) for 1 h at 37°C. 75 μL of either a γ-H2AX synthetic

Cell lines were plated in logarithmic-phase of growth in tissue culture

peptide standard or whole cell extract (UACC-257 parental, vector,

dishes and counted daily for 7 days using a cell counter (Cellometer

and NOX5 over expressor) was then added to each well and incubated

Auto T4, Nexcelom Bioscience, Lawrence, MA). For experiments

for 18 ± 2 h at 4°C. Plates were then incubated with 100 μL/well of

comparing growth of UACC-257-NOX5 overexpressing cells to the

2 μg/mL histone H2AX rabbit polyclonal antibody (Abcam, # ab11175)

parental cells and vector controls, 10 000 cells were seeded, and for

diluted in 2% BSA/PBS, supplemented with 1 μL/mL mouse serum for

experiments comparing the growth of the UACC257-shNOX5 cells

2 h at 24°C. A total of 100 μL/well HRP-conjugated affinity-purified

relative to the parental cells and vector controls, 40 000 cells were

goat anti-rabbit antibody (KPL, Inc.) was added at a final concentration

seeded. Experiments were repeated at least three times with similar

of 1 μg/mL diluted in 2% BSA/PBS supplemented with 1 μL/mL mouse

results. For transient knockdown of NOX5 and HIF-1α in WM852 cells

serum and incubated for 1 h at 24°C. Finally, 100 μL/well of freshly

as well as transient knockdown of HIF-1α in UACC-257 cells that

prepared SuperSignal ELISA Pico Chemiluminescent Substrate (Pierce)

stably overexpress NOX5 (Clone 3), log-phase cells were trypsinized,

was added to the plate and immediately read on a Tecan Infinite M200

and 10 000 cells were transfected with 5 nM of either scrambled

Pro plate reader. The RLU (relative light unit) values were exported as

siRNA or gene specific siRNAs, and growth was evaluated by cell

an Excel file from the plate reader and pasted into a pre-set γ-H2AX

counts after 6 days. All transfections were carried out in triplicates, and

analysis template. This template automatically generated the γ-H2AX

the experiment was repeated in triplicates with similar results. To

standard curve. The average γ-H2AX level for each cell extract was

evaluate the effect of antioxidants and NADPH oxidase inhibitor on

then determined using the standard curve.

the growth of UACC-257 cells that stably overexpress NOX5, logphase cells (50 000 cells/sample) of UACC-257 parental, vector and
NOX5 overexpressor lines were plated in triplicate. The following day,

2.13 | Statistical analysis

the NOX5-overexpressing cells were either untreated or treated with

Results are expressed as the mean ± S.D. from at least triplicate

catalase (500, 1000, and 2000 U/mL), NAC (2 and 5 mmol/L) or DPI

experiments. Statistical differences between mean values of control

(100 and 250 nmol/L) for 48 h followed by cell counts. Experiments

and treated samples were assessed using Student's t test; P < 0.05 was

were repeated at least three times with similar results.

considered statistically significant. Significance levels were designated
as **, P < 0.01 and ***, P < 0.001 throughout.

2.11 | Flow cytometry analysis of 5-bromo-2′deoxyuridine (BrdU) incorporation
BrdU incorporation into DNA was detected using an FITC BrdU Flow
Kit (#559619, BD Biosciences, San Jose, CA). UACC-257 cells were
serum starved for 24 h and then cultured in serum-containing media

3 | RESULTS
3.1 | Human melanomas and melanoma cell lines as
well as epithelial malignancies express NOX5

for 24 h. Cells were pulse-labeled with 10 µmol/L BrdU during the last

Recently, our laboratory reported substantial expression of NOX5 in

30 min of incubation in serum-containing media. The labeled cells were

several human cancers with weak expression in non-malignant
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tissues.22 Additionally, an initial screening of human tumor cell lines,

Subsequent functional studies were carried out using vector clone 1 and

including the NCI-60 cancer cell line panel, as well as an evaluation of

NOX5-overexpressor clone 3. To generate stable NOX5 knockdown

tumor and adjacent normal tissues from surgical resections, also

cells, parental UACC-257 cells were transfected with either a scrambled

demonstrated NOX5 expression in breast, prostate, and melanoma

shVector or shNOX5 plasmid. Three different shNOX5 plasmid

cancer cell lines, as well as in human melanomas that had been

sequences targeting distinct sequences of NOX5 were used. After

45

To broaden the scope of our initial findings and

selection and screening (detailed in section 2), two UACC257-shVector

substantiate the relevance of NOX5 expression in various tumors, here

clones (Clones 1 and 2) and three UACC257-shNOX5 clones containing

we performed a comprehensive analysis of the frequency of NOX5

different NOX5 targeting sequences (Clones 1, 2, and 3) were validated

expression over a wide range of tumor microarrays. As observed in

for NOX5 expression levels by both real-time PCR and Western analysis

Figure 1, with representative images of NOX5 expression in various

(Figure 2C, left and right panels, respectively).

removed at surgery.

tumors, significant expression of NOX5 was observed in melanoma
and cancers of the prostate and breast. Tables 1 and S1 demonstrate
expression of NOX5 in 680/750 melanomas (91%), 132/147 colon
cancers (90%), 219/230 breast carcinomas (95%), 96/161 ovarian
carcinomas (60%), and 152/175 prostate cancers (87%). Normal
human breast and prostate tissues exhibited NOX5 positive staining;

3.2 | Endogenous NOX5 and its stable
overexpression in UACC-257 cells has functional
oxidase activity that is FAD- and Ca2+-dependent
and inducible by PMA and ionomycin

however, both staining intensity and the percentage of positive cells

To assess the correlation between endogenous and overexpressed NOX5

was lower than in the corresponding tumors. Positive but weak NOX5

levels and functional NOX activity, production of both intracellular and

staining was observed for 60/85 small intestinal carcinomas (70%), 9/

extracellular ROS was determined. Intracellular ROS production was

23 stomach carcinomas (39%), and 46/150 lung carcinomas (31%).

visualized by confocal microscopy using the redox-sensitive dye

Significant expression of NOX5 observed in malignant melanomas

H2-DCFDA. As observed in Figure 3A (upper panel), increased levels

prompted us to evaluate the relative expression of NOX5 across a

of green fluorescence (DCF) were observed in UACC257-NOX5 over-

panel of human melanoma cell lines. Figure 2A shows the expression of

expressing cells compared to the parental or vector-transfected UACC-

NOX5 mRNA across the 22 human melanoma cell lines screened. A

257 cells, indicative of increased intracellular ROS production. Addition-

wide range of expression was observed across the cell line panel with

ally, exposure to the calcium ionophore ionomycin significantly enhanced

low, intermediate, and high level NOX5 mRNA expressors. RT-PCR

the DCF fluorescence in the NOX5-overexpressing cells by about 2.5-fold

was performed in the moderate to high NOX5 expressing SK-MEL-5

compared to both the parental and vector controls (Figure 3A, lower

and UACC-257 cells with specific primers that detect the seven

panel). A similar increase in intracellular ROS levels that was further

homologs of the NADPH oxidases. A PCR product corresponding to

enhanced by ionomycin was observed in the UACC-NOX5 overexpress-

the expected NOX5 sequence (144 bp) was detected in both of these

ing cells by flow cytometry (data not shown). These results are in concert

melanoma cell lines (Supplementary Figure S1).42 Expression of other

with previous studies that have demonstrated the enhancement of NOX5

NOX family members was minimal or undetectable. To further

activity by calcium ionophore, consistent with its EF-hand Ca2+-binding

delineate the NOX5 variant present in these melanoma cell lines,

domains.35,36,46 Extracellular H2O2 production was detected using the

primers were designed that would generate PCR products of 326 bp

Amplex Red reagent in conjunction with HRP. As shown in Figure 3B,

for NOX5α, 577 bp for NOX5β, 451 bp for NOX5γ, and 661 bp for

NOX5 can be activated both by the protein kinase C enhancing phorbol

NOX5δ.43 RT-PCR revealed that the human melanoma cells express

ester PMA,47,48 and by the Ca2+ ionophore ionomycin to generate

the long form functional variants of NOX5 (NOX5-L); UACC-257 cells

extracellular H2O2 (P < 0.05).47–49 Furthermore, NOX5 activity is inhibited

expresses NOX5α and NOX5γ, and the SK-MEL-5 line expresses all

by nanomolar concentrations of the flavoprotein inhibitor diphenyle-

four (α, β, γ, and δ) NOX5 variants (Supplementary Figure S1).

neiodonium (DPI; 200 nmol/L which produces very modest effects on the

To further investigate the role of NOX5 in human melanoma,
subsequent studies were carried out in UACC-257 cells that

electron transport chain)50,51 as evidenced by a significant inhibition of
PMA- and ionomycin-mediated H2O2 production (Figure 3B).

endogenously have moderately high NOX5 expression. Additionally,

We next determined extracellular superoxide production by the

modulation of NOX5 levels in these cells was achieved by generating

luminol chemiluminescence assay and validated that the measured

stable NOX5 overexpressing (Figure 2B) and NOX5 knockdown

ROS is NOX5-mediated by using siRNA to specifically downregulate all

(Figure 2C) UACC-257 clones. To generate stable NOX5-overexpres-

isoforms of NOX5. In Figure 3C, parental UACC-257 cells (upper panel)

sors, parental UACC-257 cells were transfected with either the vector

were transiently transfected with either a non-specific scrambled

control pcDNA 3.1 or the pcDNA-HA-NOX5β plasmid. Several stable

siRNA or with three different NOX5 siRNA primers (primers 1, 2, and 3)

transfectant clones that overexpress HA-tagged-NOX5 as well as the

and evaluated for superoxide production after 3 days. Figure 3C (upper

vector alone were generated and screened. Of these, vector clones

panel) shows that extracellular superoxide production in UACC-257

(UACC257-Vector Clones 1 and 2) and stable NOX5-overexpressors

cells transfected with scrambled siRNA was modestly enhanced by the

(UACC257-NOX5- Clones 1, 2, and 3) were evaluated for NOX5 mRNA

phorbol ester PMA. However, cells transfected with three different

expression by quantitative real-time PCR and NOX5 protein expression

NOX5 siRNA primers showed a significant decrease in superoxide

by Western analysis (Figure 2B, left and right panel, respectively).

production and failed to increase superoxide production when treated
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FIGURE 1 Patterns of expression of NOX5 in human multi-tumor microarrays. (A) Representative images for NOX5 positivity to define the
criteria for 0 (negative), 1+ (weak), 2+(moderate), and 3+ (high positive) scoring of NOX5 staining intensity. All represented images are melanoma
cases, ×100 magnification; hematoxylin counterstained. Inset, Strong predominantly cytoplasmic and focal membranous expression of NOX5 in a
lymph node metastatic melanoma (blue arrow). Image, ×350 magnification; hematoxylin counterstained. (B) NOX5 expression in malignant
melanoma (upper panel), prostate adenocarcinoma (middle panel), and invasive ductal carcinoma of the breast (lower panel) relative to their
corresponding normal tissue. IstoypeIgG staining controls are also represented. All images, ×200 magnification; hematoxylin counterstained
with PMA (Figure 3C, upper panel). Likewise, when the stable

the uninduced condition, whereas, NOX5 siRNA transfection signifi-

UACC257-NOX5 overexpressing clone 3 was transiently transfected

cantly inhibited PMA-induced superoxide production. Pretreatment of

with either a scrambled siRNA or NOX5 siRNA (Figure 3C, lower

both the scrambled transfected UACC-257 and UACC257-NOX5

panel), a modest decrease in superoxide production was observed in

overexpressing cells with 200 nmol/L DPI for 2 h significantly inhibited

ANTONY

ET AL.

TABLE 1

|

2651

Immunohistochemical analysis of NOX5 expression in melanoma, prostate and breast tumors, and normal tissues

Organ

Tumor type/
Pathologic
diagnosis

No. [+] (%)

No. [−] (%)

Low expressors
(weak); No. (%)

High expressors
(Moderate + Strong);
No. (%)

Staining pattern
C = Cytoplasmic,
M = Membranous

All

Melanoma

680/750 (91%)

70/750 (9%)

311/680 (46%)

369 (54%)

C, occasional M

Cell line

Melanoma

13/13 (100%)

0/13 (0%)

4/13 (31%)

9 (69%)

C

Skin

Normal

0/3 (0%)

3/3 (100%)

0/3 (0%)

0 (0%)

Regional
skin

Melanoma

10/10 (100%)

0/10 (0%)

5 (50%)

5 (50%)

C

Distant skin

Melanoma

79/85 (93%)

6 (7%)

35 (44%)

44 (55%)

C

Lymph node

Melanoma

251/272 (92%)

21 (8%)

112 (45%)

139 (55%)

C

Sentinel
lymph
node

Melanoma

11/12 (92%)

1 (8%)

4 (36%)

7 (64%)

C

Soft tissue

Melanoma

9/12 (75%)

3 (25%)

3 (33%)

6 (67%)

C

Muscle

Melanoma

16/19 (84%)

3 (16%)

9 (56%)

7 (44%)

C

Bone

Melanoma

11/11 (100%)

0 (0%)

7 (64%)

4 (36%)

C

Brain

Melanoma

16/19 (84%)

3 (16%)

3 (18%)

13 (82%)

C

Lung

Melanoma

71/78 (90%)

7 (10%)

32 (45%)

39 (55%)

C

Bowel

Melanoma

87/95 (92%)

8 (8%)

50 (57%)

37 (43%)

C

Stomach

Melanoma

10/12 (83%)

2 (17%)

8 (80%)

2 (20%)

C

Liver

Melanoma

22/24 (92%)

2 (8%)

8 (36%)

14 (64%)

C

Spleen

Melanoma

14/16 (88%)

2 (12%)

7 (50%)

7 (50%)

C

Pancreas

Melanoma

18/20 (90%)

2 (10%)

10 (55%)

8 (44%)

C

Gallbladder

Melanoma

2/2 (100%)

0 (0%)

1 (50%)

1 (50%)

C

Adrenal
gland

Melanoma

25/32 (78%)

7 (22%)

8 (32%)

17 (68%)

C

Kidney

Melanoma

9/11 (82%)

2 (18%)

1 (11%)

8 (89%)

C

Ovary

Melanoma

6/6 (100%)

0 (0%)

3 (50%)

3 (50%)

C

Peritoneum

Melanoma

13/14 (93%)

1 (7%)

5 (38%)

8 (62%)

C

Lymph node

Normal

7/24 (29%)

17 (71%)

4 (57%)

3 (43%)

C

Sentinel
lymph
node

Normal

2/6 (33%)

4 (67%)

2 (100%)

0 (0%)

C

Muscle

Normal

0/3 (0%)

3 (100%)

0 (0%)

0 (0%)

Bone

Normal

0/2 (0%)

2 (100%)

0 (0%)

0 (0%)

Brain

Normal

1/3 (33%)

2 (67%)

1 (100%)

0 (0%)

Lung

Normal

0/3 (0%)

3 (100%)

0 (0%)

0 (0%)

Bowel

Normal

2/2 (100%)

0 (0%)

0 (0%)

2 (100%)

C

Liver

Normal

7/8 (88%)

1 (12%)

1 (14%)

6 (86%)

C

Spleen

Normal

0/4 (0%)

4 (100%)

0 (0%)

0 (0%)

Pancreas

Normal

3/3 (100%)

0 (0%)

0 (0%)

3 (100%)

C

Gallbladder

Normal

2/4 (50%)

2 (50%)

1 (50%)

1 (50%)

C

Adrenal

Normal

3/3 (100%)

0 (0%)

0 (0%)

3 (100%)

C

Kidney

Normal

0/1 (0%)

1 (100%)

0 (0%)

0 (0%)

Ovary

Normal

0/2 (0%)

2 (100%)

0 (0%)

0 (0%)

C

Organ: Prostate
Tumor type/
Pathologic
diagnosis
Carcinoma (All)

Subtype

No. [+] (%)

No. [−] (%)

Low expressors
(weak); No. (%)

152/175 (87%)

23/175 (13%)

124 (82%)

High expressors
(Moderate + Strong);
No. (%)

Staining Pattern
C = Cytoplasmic,
M = Membranous

28 (18%)

C

(Continues)
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(Continued)

Organ: Prostate
Tumor type/
Pathologic
diagnosis

High expressors
(Moderate + Strong);
No. (%)

Staining Pattern
C = Cytoplasmic,
M = Membranous

Subtype

No. [+] (%)

No. [−] (%)

Low expressors
(weak); No. (%)

Adenocarcinoma

148/171 (87%)

23/171 (13%)

122 (82%)

26 (18%)

C/stromal

Transitional cell
carcinoma

4/4 (100%)

0/4 (100%)

2 (50%)

2 (50%)

C/luminal secretion/
stromal

17/17 (100%)

0/17 (0%)

15 (88%)

2 (12%)

C/luminal secretion/
stromal

Normal prostate
tissue

6/6 (100%)

0/6 (0%)

4 (67%)

2 (33%)

C/luminal secretion/
stromal

Adjacent normal
prostate
tissue

11/11 (100%)

0/11 (0%)

11 (100%)

0 (0%)

C/luminal secretion/
stromal

219/230 (95%)

11/230 (5%)

148 (68%)

71 (32%)

C

Invasive ductal
carcinoma

211/219 (96%)

8/219 (4%)

140 (66%)

71 (34%)

C

Invasive lobular
carcinoma

4/5 (80%)

1/5 (20%)

4 (100%)

0 (0%)

C

Tubular
carcinoma

1/1 (100%)

0/1 (0%)

1 (100%)

0 (0%)

C

Mucinous
carcinoma

1/1 (100%)

0/1 (0%)

1 (100%)

0 (0%)

C

Medullary
carcinoma

2/4 (50%)

2/4 (50%)

2 (100%)

0 (0%)

C

Normal (All)

Organ: Breast
Carcinoma (All)

Normal (All)

5/6 (83%)

1/6 (17%)

4 (80%)

1 (20%)

C

Normal breast
tissue

1/1 (100%)

0/1 (0%)

0 (0%)

1 (100%)

C

Cancer adjacent
normal breast

4/5 (80%)

1/5 (20%)

4 (100%)

0 (0%)

C

Relative staining intensities observed for NOX5 expression are represented in columns 3 and 4. Staining intensities for NOX5 expression was assessed as
either 0/−, negative/no or blush staining; 1+, weak, 2+, moderate; and 3+, strong. Cases with NOX5 staining intensities (1+, 2+, and 3+) are represented in
column 3 [+], and cases negative for NOX5 staining are represented in column 4 [−]. Additionally, the percentage of stained tumor/lesion cells was also
estimated for each case where, 0, 0% to <10% were considered negative; 1, 10-24%, 2, 25-49%, 3, ≥50% of positive cells. Cases with moderate to strong
cytoplasmic reactivity of the antibody on ≥10% of cells were considered high expressors (column 6). NOX5 staining pattern observed is denoted as either
cytoplasmic (C) or membranous (M).

superoxide production. Addition of the intracellular calcium chelator

gated whether NOX5-mediated ROS can regulate HIF-1α in UACC-257

BAPTA-AM (10 µmol/L) or superoxide dismutase (SOD) at the time of

cells. As shown in Figure 4A, under normoxic conditions, increased levels of

the assay also essentially abolished superoxide production, indicative

HIF-1α protein were observed in NOX5 overexpressing clones. Conversely,

of functional NOX5-mediated superoxide formation in UACC-257

decreased HIF-1α protein levels were observed in NOX5 knockdown

cells. Accordingly, Figure 3D shows the stable NOX5 knockdown

clones (shNOX5). Enhanced normoxic HIF-1α levels were inversely

clones of UACC-257 that have a significant decrease in superoxide

correlated with the levels of the cell cycle regulatory protein p27kip1

production compared to the vector control and that fail to increase

(Figures 4A and S2A). To validate our observation that NOX5 over-

superoxide production when treated with PMA, confirming the ROS to

expression was associated with increased normoxic HIF-1α and decreased

be NOX5-mediated.

p27kip1 levels, the effect of NOX5 knockdown was next evaluated
(Figures 4B and 4C, and Supplementary Figures S2B and S2C). To this end,

3.3 | NOX5-derived ROS regulates normoxic HIF-1α
and p27Kip1 expression in tumor cell lines of varying
histological origins

NOX5 was transiently depleted by siRNA in the NOX5-overexpressing
clone 3 (Figures 4B and S2B) and in parental UACC-257 cells
(Figures 4C and S2C) with different NOX5-specific siRNAs (primers 1-3).
Compared with untransfected cells or cells transfected with scrambled

Because ROS have previously been shown to be part of the signaling

control siRNA, HIF-1α protein levels were markedly reduced in NOX5-

cascades regulating HIF-1α under non-hypoxic conditions,52 we investi-

depleted cells (Figures 4B and 4C, and Supplementary Figures S2B and S2C).
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A corresponding increase in p27Kip1 expression was observed in cells that

context. As shown in Figure 4, UACC-257 cells exhibit decreased p27Kip1

were knocked down for NOX5 expression (Figures 4B and 4C, and

expression when NOX5 expression is increased, and conversely,

Supplementary Figures S2B and S2C). Consistent with what we observed

increased p27Kip1 levels when NOX5 expression is knocked down. To

for NOX5 overexpression (Figures 4A and S2A), knockdown of NOX5

further investigate the ROS-mediated regulation of p27Kip1 levels in the

expression in both parental UACC-257 cells and NOX5-overexpressing

context of NOX5 expression levels, parental UACC-257 cells were

clones reversed the expression levels previously observed: decreasing HIF-

transiently transfected with two different NOX5 specific siRNAs and their

1α and increasing p27Kip1 levels. Here, we identify for the first time that HIF-

effects on p27Kip1 localization and phosphorylation were evaluated (see

Kip1

1α and p27

are key molecules regulated by NOX5-mediated ROS in

Figures 5A and S5A). Decreased expression of NOX5 leads to
accumulation of p27Kip1 both in the cytoplasm and the nucleus. Similarly,

UACC-257 cells.
To confirm the functional relevance of NOX5-generated ROS in the

transient knockdown of NOX5 expression with siRNAs in UACC257-

observed increase of normoxic HIF-1α, the NOX5-overexpressing cells

NOX5 overexpressing cells also demonstrated an increase of p27Kip1

(UACC257-NOX5-Clone 3) were either treated with the reduced thiol and

accumulation both in the cytoplasm as well as the nucleus (Figures 5B and

glutathione precursor N-Acetyl-L-Cysteine (NAC, 10 mmol/L, 24 h), PEG-

S5B). The phosphorylation of p27Kip1 at T157 and S10 were not significantly

Catalase (2000 U/mL, 24 h), or PEG-SOD (150 U/mL, 24 h). Treatment

altered (Figures 5A and S5A). However, alterations in the expression of

with NAC completely prevented NOX5-mediated normoxic HIF-1α

known regulators of p27Kip1 were observed following NOX5 depletion. A

Kip1

downregulation, suggesting the involvement of

decrease in the phosphorylation of Akt at Ser473 and a decrease in the

ROS in this response (Figures 4D and S2D). A similar, albeit lesser,

phosphorylation of GSK3β at Ser9 with no significant effect on the

decrease of the normoxic HIF-1α levels and increase in p27Kip1 levels was

expression of the corresponding total proteins were observed upon

observed

knockdown of NOX5 expression (Figures 5A and S5A).

upregulation and p27

with

both

PEG-Catalase

and

PEG-SOD

treatment

(Figures 4D and S2D). Further investigation revealed that the decrease

To examine the physiological relationship between NOX5, HIF-1α, and

in p27Kip1 levels in our stable NOX5 overexpressing cells could, in part, be

p27Kip1expression status and to determine whether NOX5-mediated

transcriptionally regulated because of a modest decrease observed in

regulation of p27Kip1 expression is HIF-1α dependent, expression levels of

Kip1

p27

mRNA expression following NOX5 overexpression (Figure 4E).

normoxic HIF-1α transcript levels (Supplementary Figure S6A) and protein

Quantitative real-time PCR confirmed that the accumulation of normoxic

levels (Supplementary Figure S6B) across a panel of melanoma cell lines

HIF-1α is likely a translational event, rather than due to a transcriptional

were evaluated. No significant correlation of expression of HIF-1α levels in

regulation, because no accumulation of HIF-1α transcripts was observed

normoxia to endogenous NOX5 levels was observed. However, transient

with either NOX5 knockdown or overexpression (Figure 4F).

knockdown of HIF-1α under normoxic conditions in UACC-257 cells that

To evaluate NOX5-mediated effects on normoxic HIF-1α and

stably overexpress NOX5 (Supplementary Figure S6C), and in an additional

p27Kip1 levels further, additional cell types including an inducible NOX5-

melanoma WM852 cell line (Supplementary Figure S6D), resulted in a slight

overexpressing UACC-257 system, human WM852 melanoma cells,

increase of p27Kip1 protein levels, suggesting that the regulation of p27Kip1

human KARPAS 299 lymphoma cells, and human PC-3 prostate cancer

expression directly by HIF-1α is minimal or modest at best.

cells were examined. As demonstrated in Supplementary Figure S3,

Another known mechanism governing p27Kip1 regulation is S-

inducible NOX5-overexpression in UACC-257 cells (Supplementary

phase kinase-associated protein 2 (SKP2)-mediated degradation.53 To

Figure S3A), stable NOX5 overexpressing KARPAS 299 cells (Supple-

assess whether the NOX5-related decrease in p27Kip1 expression is

mentary Figure S3B), and stable NOX5 overexpressing PC-3 cells

dependent on or mediated in part by SKP2, the relevance of SKP2

(Supplementary Figure S3C) is functional and generates ROS as

expression to NOX5 and p27Kip1 was evaluated. No significant

measured by luminol chemiluminescence. Functional NOX5 over-

correlation between the expression status of SKP2 and NOX5 was

expression in these cells also produces normoxic HIF-1α upregulation

observed in a panel of melanoma cell lines (compare Supplementary

and p27Kip1 downregulation (Supplementary Figure S4A). Conversely, in

Figures S7A and S7B with Figure 2A). Additionally, comparing UACC-

the WM852 melanoma line, transient knockdown of endogenous NOX5

257 cells that have been genetically altered for NOX5 expression

results in HIF-1α downregulation and p27Kip1 upregulation (Supple-

(stable NOX5 knockdown and stable NOX5 overexpression) did not

mentary Figure S4B). Likewise, knockdown of endogenous NOX5 in

show alterations in SKP2 levels (Supplementary Figure S7C), suggest-

parental PC-3 cells leads to p27Kip1 upregulation, and knockdown of

ing that NOX5-mediated regulation of p27Kip1 is not SKP2 mediated.

overexpressed NOX5 in PC-3 cells demonstrates HIF-1α down-

While multiple mechanisms are involved in the regulation of p27Kip1

regulation (Supplementary Figure S4C). These results strongly suggest

accumulation, taken together, our results suggest that independent of

Kip1

that HIF-1α stabilization and p27

levels are regulated, at least in part,

HIF-1α and SKP2, NOX5-mediated ROS may regulate p27Kip1and the

through NOX5-mediated ROS production in human tumor cells.

Akt/GSK3 signaling pathways.

3.4 | Regulation of nuclear p27Kip1 accumulation by
NOX5-mediated ROS

3.5 | NOX5 expression modulates γH2AX levels and
growth of human UACC-257 melanoma cells

It has been documented that reactive oxygen production may be linked to

We next evaluated the effect of NOX5 expression on the growth of

either up- or down-regulation of p27Kip1 expression, depending on cell

UACC-257 cells. As shown in Figure 6A, the UACC257-NOX5
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FIGURE 2 NOX5 expression in human melanoma cell lines. Total RNA was extracted from human melanoma cell lines. (A) Quantitative
real-time PCR was carried out to detect endogenous NOX5 expression. Values are expressed relative to β-Actin. (B and C) Stable
overexpression (B) and stable knockdown (C) of NOX5 in UACC-257 cells. UACC-257 cells were transfected with either the vector pcDNA
3.1 or pcDNA3-HA-NOX5β plasmid for stable NOX5 overexpression (B); and with either scrambled shVector or shNOX5 plasmids for stable
NOX5 knockdown (C). Several clones were isolated after G418 selection, of which two clones (Clone 1 and 2) for each of the vector plasmids
(pcDNA 3.1 and scrambled sh) and three clones (Clone 1, 2, and 3) for both the NOX5-overexpressing and NOX5-knockdown were evaluated
for further studies. NOX5 expression was confirmed at the mRNA level (left panel; B and C) and at the protein level (right panel; B and C). To
visualize endogenous expression of NOX5 relative to the NOX5 overexpressors and the decrease of NOX5 expression in the NOX5
knockdowns relative to the endogenous NOX5, additional NOX5 (long exposure [2-5 min] and very long exposure [5-10 min] of film) panels
are represented. The HA-tag expression confirmed the specificity of the antibody for NOX5 expression. Tables on the right (panels B and C)
represent the densitometric expression of NOX5 protein expression (long exposure) relative to that of β-Actin
overexpressing cells exhibit enhanced cell proliferation when com-

24 h and subsequently released in growth medium for an additional

pared to either the parental or the vector control (three independent

24 h; NOX5 overexpressors demonstrate an ∼1.5- to 2-fold increase in

experiments; P < 0.01). This enhanced cell growth was also supported

the number of BrdU positive cells relative to the parental and vector

by measurement of BrdU incorporation in cells that were starved for

control cells (Figure 6B). To assess whether the enhanced cell growth
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FIGURE 3 Intracellular and extracellular ROS produced by NOX5 in UACC-257 cells is Ca2+- and flavin-dehydrogenase dependent. (A)
upper panel, Ionomycin induces NOX5-mediated ROS production as measured by confocal microscopy. Live staining of log-phase UACC-257
cells was performed as described in section 2. Higher ROS levels were observed in UACC-NOX5-clone 3 cells stimulated with ionomycin
(1 µmol/L) than in parental or vector transfected clones. Representative confocal images of ROS production as detected by DCF fluorescence
(green) and corresponding phase-contrast fields are shown. The lower panel provides the quantitation of fluorescent intensities for three
separate experiments. (B) Extracellular ROS production by overexpression of NOX5 was detected after 30 min of treatment with the phorbol
ester PMA (500 nmol/L) or by the Ca2+ ionophore ionomycin (1 µmol/L) using the Amplex Red assay. H2O2 levels were calculated with a
standard curve of 0-2 µmol/L H2O2. The NOX5 enzymatic activity is flavin dehydrogenase-dependent since pretreatment of cells with the
flavoprotein inhibitor DPI (200 nmol/L) for 2 h significantly decreased NOX5-mediated ROS production. (C) Silencing NOX5 by RNAi
significantly inhibited endogenous-, overexpressed-, and PMA-stimulated ROS production. Parental UACC-257 cells (upper panel) and the
NOX5-overexpressing clone 3 (lower panel) were transiently transfected with either control scrambled siRNA or NOX5-specific siRNAs
targeting different domains of human NOX5 (primers 1-3). After 72 h of transfection, cells were trypsinized and analyzed for the effects of
transient silencing of NOX5 expression on ROS production in the parental and NOX5-overexpressing cells in the absence and presence of
200 nmol/L PMA (added immediately at the start of the assay) by luminol chemiluminescence assay. To inhibit NOX5 activity, scrambled
siRNA control cells were either pretreated with DPI (200 nmol/L) for 2 h in culture medium or treated with BAPTA (10 µmol/L) at the time of
the assay. SOD was used to confirm superoxide generation. (D) Log-phase UACC-257 cells that have been stably knocked down for NOX5
(UACC-257-shNOX5-clones 1, 2, and 3) and its appropriate vector control cells (UACC257-Vector-Clone 1) were trypsinized and analyzed for
the effects of stable knockdown of NOX5 expression on ROS production by luminol chemiluminescence assay in the absence and presence of
200 nmol/L PMA (added immediately at the start of the assay). Significant inhibition of both endogenous and PMA-stimulated ROS
production in UACC-257 cells with stable knockdown of NOX5 expression (UACC-257-shNOX5-clones 1, 2, and 3) relative to the
appropriate vector control cells (UACC257-Vector-Clone 1) was observed. **, P < 0.01
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FIGURE 4 NOX5 expression levels in human UACC-257 melanoma cells affect normoxic HIF-1α and p27Kip1 expression. (A) Whole cell
lysates from log-phase UACC-257-vector control clones (scrambled-sh and pcDNA3.1), UACC257-shNOX5 clones (1-3), and UACC257NOX5-overexpressing clones (2 and 3) were prepared and analyzed by Western blotting. NOX5 overexpression in UACC-257 cells results in
decreased p27Kip1 expression as well as increased normoxic HIF-1α expression. Conversely, decreased normoxic HIF-1α and corresponding
increased p27Kip1 expression was observed in NOX5 knockdown cells. (B and C) Transient knockdown with NOX5-specific siRNA primers
targeting different domains of human NOX5 in the stably overexpressing NOX5 clone (B) and parental UACC-257 cells (C) results in
decreased normoxic HIF-1α and corresponding increased p27Kip1 expression. (D) Increased normoxic HIF-1α and decreased p27Kip1
expression observed in NOX5-overexpressing cells is ROS-dependent. The NOX5-overexpressing UACC257 clone was treated with NAC or
PEG-Catalase or PEG-SOD and examined by Western analysis. Densitometric analysis of western blot analyses (Panels A-D) of the expression
of the various proteins relative to that of β-Actin are represented in Supplementary Figure S3. (E) Total RNA was isolated from log phase
parental UACC-257 cells, UACC-257 cells that were transiently transfected with either scrambled control or two different NOX5-specific
siRNAs, and UACC-257 clones that stably overexpress either NOX5 or the vector. Real-time PCR analysis of p27Kip1 mRNA expression levels
are expressed relative to β-Actin. (F) Total RNA from parental UACC-257 cells and stable NOX5-overexpressing clone 3 cells transiently
transfected with either a scrambled siRNA or NOX5-specific siRNAs, stable vector clones and two additional NOX5 overexpressing clones
were isolated. Real-time PCR analysis of HIF-1α mRNA levels are expressed relative to β-Actin. **, P < 0.01
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observed in the UACC257-NOX5 overexpressing cells was ROS-

sample sizes of the tissues examined and/or the immunohistochemical

mediated, the UACC257-NOX5 overexpressing cells were treated

detection method using different NOX5 antibodies.24 While epige-

with either antioxidants (catalase and NAC) or the flavoprotein

netic regulation of NOX5 expression has only recently begun to be

inhibitor DPI. Figure 6C shows a dose dependent decrease in cell

explored, it is one of many possible explanations for the down/up

growth of UACC257-NOX5 overexpressing cells by catalase, NAC and

regulation of NOX5 expression in cultured cell lines, an area of

DPI; indicative of a ROS-mediated role in their proliferation (two

investigation that remains largely unexplored.

independent experiments; P < 0.01). To examine the possibility that

Because pathological evidence suggested a role for NOX5 in

NOX5-related ROS might contribute to enhanced genetic instability of

human melanomas, we next assessed whether the intracellular redox

UACC-257 cells, we evaluated the activation of phosphorylated

status regulated by NOX5 was critical for the proliferation of

γH2AX, a biomarker for DNA damage and repair. As shown in

melanoma lines. HIF-1α, a known sensor of cellular oxidant load,

Figure 6D, we found 30% more phosphorylated γH2AX in the NOX5

which regulates the expression of a wide variety of proliferative and

overexpressors compared to the parental and vector control cells.

angiogenic genes, was significantly upregulated in the context of

Conversely, stable knockdown of NOX5 expression in UACC-257 cells

NOX5-generated ROS. Under normoxic conditions, HIF-1α expression

(see Figure 6E) and transient knockdown of NOX5 expression in

was significantly increased in cells that overexpress NOX5; conversely,

WM852 cells (see Figures 6F and S8) substantially decreased cell

HIF-1α levels were decreased in NOX5-deficient cells (Figures 4

proliferation (three independent experiments; P < 0.01); suggesting

and 5A, and Supplementary Figures S2, S4, and S5A) albeit

that NOX5-mediated pro-oxidant tone is necessary for the prolifera-

physiologically not correlated across a panel of melanoma cell lines

tion of UACC-257 and WM852 cells.

(compare Figure 2A with Supplementary Figures S6A and S6B). Several
mechanisms of ROS-dependent upregulation of HIF-1α protein levels
have been described under both normoxic and hypoxic conditions.56

4 | DISCUSSION

This regulation of HIF-1α can either be at the level of protein stability
or its synthesis. Transcriptionally, regulation of HIF-1α synthesis has

A pro-oxidant environment favoring tumor cell growth has been

been attributed to the activation of NF-κB and its binding to the HIF-

supported by several studies showing upregulated expression and/

1α promoter or to regulation by the activation of MAPK/Akt signaling

or activity of ROS generating proteins and their downstream

pathways.57,58 Translationally, HIF-1α levels are increased by the

signaling effectors.2,7,10,54 In this investigation, our TMA analyses

altered regulation and inactivation of prolyl hydroxylases, in part

substantiate the observation that NOX5 is significantly overex-

through the oxidation of critical stores of Fe2+; diminished levels of

pressed in melanomas and cancers of the prostate and breast (see,

intracellular reducing equivalents, such as ascorbate, that maintain the

Figure 1, Tables 1 and S1) compared to non-malignant tissues of the

iron redox state could decrease the degradation of HIF-1α protein.59

same histological origin. Particularly in the context of human

Under hypoxic conditions prolyl hydroxylation and ubiquitin-mediated

melanoma, NOX5 positivity in 91% of the cases studied compared

proteasomal degradation of HIF-1α are suppressed, resulting in HIF-

to a lack/minimal NOX5 staining in normal human skin was

1α accumulation and stabilization by dimerization with HIF-1β.60 As

significant. As detailed in Table 1, among the 680 out of 750

seen in Figure 4F, transcriptional levels of HIF-1α in UACC-257 cells

human melanoma patient samples that stained for NOX5 expression,

remained unaltered irrespective of an increase or a decrease in NOX5

≥75% of the cells were positive in 84% of the cases. Additionally, in

expression, suggesting that HIF-1α regulation by NOX5 may be

83 of these patients, the NOX5 staining was strong (3+).

primarily translational by one or another oxidant-sensitive effects.

Surprisingly, under standard tissue culture conditions, the majority

Addition of PEG-catalase and PEG-SOD (to increase intracellular ROS

of the human melanoma cell lines we screened have low to minimal

detoxifying capacity)61 or a ROS scavenger N-Acetyl-L-Cysteine (NAC)

expression of the NOX5 transcript (Figure 2A). This apparent

to UACC-257 cells overexpressing NOX5 significantly decreased

discrepancy between NOX5 expression levels in human melanoma

NOX5-upregulated HIF-1α expression (Figure 4D), confirming HIF-1α

patient samples versus tissue cultured cell lines is not an anomaly; our

upregulation to be mediated by NOX5-generated ROS signaling. This

laboratory and others have documented that expression of some

normoxic NOX5-ROS-HIF-1α signaling axis sets up a pro-inflamma-

members of the NOX gene family (particularly NOX1 and DUOX2) is

tory milieu that could serve as a potent angiogenic stimulus, conducive

strongly upregulated under proinflammatory conditions both in vitro

to enhanced tumor growth and invasion.62

55

In contrast, a discordance

Notably, the expression levels of p27Kip1, a member of the Cip/Kip

in the opposite direction between NOX5 expression in clinical

family, known to modulate cell cycle progression were also

specimens and cultured cell lines was recently reported in prostate

significantly influenced by NOX5 expression. In cells that stably

cancer, wherein, prostate cancer cell lines demonstrated higher NOX5

overexpress NOX5, p27Kip1 protein levels were decreased; and

protein expression levels compared to non-malignant prostate cell

conversely, cells with decreased NOX5 expression exhibited increased

lines, while no significant difference was observed in clinical speci-

p27Kip1 levels (Figures 4, 5, and Supplementary Figures S2, S4, and S5).

(following cytokine exposure) and in vivo.

24

This discordance with our observation of increased NOX5

Downregulation of p27Kip1 protein levels, in particular nuclear p27Kip1,

expression in prostate cancer clinical samples relative to histologically

is implicated in both disease progression and poor prognosis in a

normal prostate tissue could, in part, be due to differences in the

variety of cancers.63,64 However, the effects of p27Kip1 are regulated

mens.
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FIGURE 5 Increased nuclear and cytoplasmic p27Kip1 following knockdown of both endogenous and overexpressed NOX5 in UACC-257
cells. To assess the translational regulation of p27Kip1 by NOX5, log-phase parental UACC-257 cells (A) or UACC-NOX5 overexpressing clone
3 (B) were transfected with either scrambled or two different NOX5-specific siRNAs. Nuclear and cytoplasmic extracts were prepared 72 h
after transfection, and the expression levels of various proteins were examined by Western analysis. Blots are representative of HIF-1α,
NOX5, Akt, phospho-Akt (Ser473), GSK3β, phospho-GSK3β (Ser9), p27Kip1, phospho-p27Kip1 (Thr157 and Ser10), Lamin A/C, and β-Actin
expression from three independent experiments. Densitometric analyses of the Western blots from panels A and B for the expression of the
various proteins are represented in Supplementary Figure S5
by concentration, subcellular localization, and phosphorylation sta-

kinases, AMPK, and PIM, that impairs its nuclear import resulting in

tus.64–66 Post-translationally, p27Kip1 is modified predominantly by

cytoplasmic localization.

phosphorylation; Thr187 phosphorylation leading to nuclear degrada-

In UACC-257 cells that stably overexpress NOX5, the observed

tion, Ser10 phosphorylation stimulating nuclear export and subsequent

decrease in p27Kip1 levels may, in part, be transcriptionally regulated

degradation, and Tyr74, Tyr88, and/or Tyr89 phosphorylation diminish-

since a modest decrease in p27Kip1 transcript levels was observed

ing its CDK-inhibitory activity. Less common and not well understood

(Figure 4E). Additionally, in both parental and stable NOX5 over-

is the phosphorylation of p27Kip1 at Thr157 and Thr198 by Akt, p90-S6

expressing cells, knockdown of NOX5 increased both nuclear and
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FIGURE 6 NOX5 expression alters the growth and DNA damage levels of UACC-257 cells. (A) NOX5 overexpression promotes the growth
of UACC-257 cells. Growth of logarithmic phase UACC-257, vector and NOX5 overexpressing cells was measured by daily cell counts;
10 000 cells were plated in triplicate for each cloned line and the parental cells. The data are expressed as the mean ± SD of three
independent experiments, **, P < 0.01. (B) Cell cycle analysis was performed using flow cytometry following BrdU labeling of UACC-257
parental and each cloned line that were serum-starved and then released in full growth media for 24 h. The percentage of cells in the
different phases of the cell cycle is shown in the table. (C) Effect of antioxidants (NAC and catalase) and the flavoprotein inhibitor
diphenyleneiodonium (DPI) was evaluated on the growth of the NOX5 overexpressing cells as measured by cell counts subsequent to 48 h
treatment. Data represent the mean ± SD of two independent experiments, **, P < 0.01. (D) γH2AX levels in exponentially growing UACC-257
parental and cloned lines were quantified using a γH2AX and H2AX sandwich ELISA immunoassay as described in the Materials and Methods
section. (E) Stable knockdown of NOX5 expression decreases the growth of UACC-257 cells. Growth of logarithmic phase UACC-257, vector,
and NOX5 knockdown cells was measured by daily cell counts; 40 000 cells were plated in triplicate for each cloned line and the parental
cells. The data are expressed as the mean ± SD of three independent experiments, **, P < 0.01. (F) Effect of transient knockdown of NOX5
expression on cell growth was evaluated in an additional melanoma cell line; WM852. Cells transfected with either scrambled siRNA or
NOX5-specific siRNA primers targeting different domains of human NOX5 were evaluated after 6 days for NOX5 RNA expression (left panel)
and for cell growth (right panel) by cell counts. The data are expressed as the mean ± SD of triplicates,**, P < 0.01 and ***, P < 0.001. The
experiment was repeated in triplicates with similar results. Representative images of the effect of NOX5 knockdown on the growth of
WM852 cells and the effect on ROS production are represented in Supplementary Figure S6
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Significantly, in the absence of NOX5 expression, the Akt/GSK3

and

signaling pathway was inhibited in UACC-257 cells, as observed by their

Thr157 were noted. Significantly, the observed alterations in p27Kip1

decreased phosphorylation (Figure 5A). Akt, an important kinase that

levels were also SKP2 independent (Supplementary Figure S7).

promotes G1-S phase cell cycle progression by phosphorylating and

The NOX5-expression dependent, reciprocal expression levels of

inactivating glycogen synthase kinase 3 (GSK3) at Ser9, is a downstream

p27Kip1 and HIF-1α in UACC-257 cells appears contradictory, as

component of signaling pathways involving protein tyrosine phosphatases

several groups have shown that during hypoxia the induction of the cell

(PTPs).77,78 Accordingly, in ROS generating NOX5 cells, PTP activity was

67

significantly inhibited (data not shown), offering one plausible mechanism

However, the regulation of p27Kip1 by HIF-1α is still an area of debate

by which NOX5-generated ROS-induced inactivation of PTPs leads to an

cycle inhibitors p21

Cip1

and p27

68

within the hypoxia field

Kip1

is dependent on HIF-1α.

as other studies have shown that p27

Kip1

is

regulated independently of HIF-1α, through transcriptional regulation
69

of its proximal promoter.

active Akt kinase, a known regulator of cell cycle genes that control
anchorage-independent growth of cancer cells.78,79

Additionally, studies to characterize the

In addition to the enhanced pro-oxidant tone conferred by NOX5

role of HIF-1α in normoxia report that knockdown of HIF-1α resulted

overexpression, we also observed that UACC-257 cells that overexpress

in significantly increased protein and mRNA of both p21Cip1 and

NOX5 proliferate faster (Figure 6A). Enhanced cell proliferation by NOX5

p27Kip1, induced via, at least in part, p53-independent but SP1-

overexpressing cells is clearly distinguishable from both parental cells and

dependent mechanisms.70 Similar reciprocal levels of expression of

vector controls after a week in culture. However, within 24 h of release

HIF-1α and p27Kip1 have been reported in LNCaP prostate cancer cells

from serum starvation, a marked increase in BrdU incorporating cells,

71

Likewise, UACC-257 cells that stably overexpress

reflective of an S-phase population, supports the enhanced growth of

NOX5 exhibit upregulated, normoxic HIF-1α expression; transiently

NOX5 overexpressing cells (Figure 6B). Interestingly, these cells were

knocking down the normoxic HIF-1α resulted in increased p27Kip1

characterized by an increase in the DNA damage and repair biomarker

protein levels, without significantly affecting cell growth (Supplemen-

γH2AX. In contrast, knocking down endogenous NOX5 expression (using

under hypoxia.

Kip1

protein expression was

three different NOX5shRNA plasmids that target different sequences in

observed in WM852 cells when normoxic HIF-1α expression was

NOX5) in UACC-257 cells markedly slows cell growth (Figure 6E),

transiently knocked down (Supplementary Figure S6D). While a

confirming that NOX5 expression regulates UACC-257 cell proliferation.

reciprocal effect of NOX5-mediated ROS on the expression levels of

Enhanced cell growth in the presence of NOX5 in UACC-257 cells could,

tary Figure S6C). A similar increase in p27

p27

Kip1

and HIF-1α is clear, evidence of a direct effect of HIF-1α on

p27Kip1 expression is minimal and at best, modest.

in part, be due to the downstream redox signaling pathways that are
activated due to altered phosphatase function.

While additional studies are needed to understand the precise

Collectively, our results suggest a new molecular paradigm by which

mechanisms associated with NOX5-redox-induced regulation of

NOX5-mediated ROS-inducible signal-transduction pathway(s) may con-

p27Kip1 expression, another possibility is an alteration in the status

tribute to the growth of melanoma cells and other human tumors,80 in part,

of redox-sensitive thiol-disulfide reactions at the two critical residues

through mechanisms that involve genomic instability and activation of the

within the cyclin A binding domain of p27Kip1.72 Although the role of

Akt/GSK3, p27Kip1, and HIF-1α signaling pathways. Intracellular redox

these cysteines in redox regulation of G1 to S phase is speculative, it is

status maintained by NOX5 is critical for sustaining cell growth and may

reasonable to suggest that thiol-redox reactions could act as

contribute to the establishment of a pro-angiogenic milieu that adversely

“sulfhydryl switches” that reversibly modulate cell cycle-regulatory

affects clinical outcome for patients with melanomas.

protein activity.73 This hypothesis is supported by our studies of BrdU
incorporation (increased S-phase fraction) which may underlie the
observed pro-proliferative effects. Redox-dependent downregulation
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